Developing, funding and conducting clinical trials in immune tolerance
A clinical trial for lupus nephritis.
Calibrate is no longer enrolling study participants
The CALIBRATE study may
be an option for you.
CALIBRATE: A Clinical Trial for Lupus Nephritis
CALIBRATE is a clinical research study testing the safety and efficacy of an investigational drug approach in lupus nephritis: treatment with rituximab (Rituxan®) and cyclophosphamide (Cytoxan®) followed by belimumab (Benlysta®).